Truvada 200 MG-300 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8XLQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,856
Award facts
- Contract value 100% obligated
- $22,856.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,856.41 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, was executed without set-aside provisions, indicating full and open competition. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, designated as SPE2DX and valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with DLA includes delivery of diverse pharmaceutical products spanning multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical supplies. The parent organization, Cencora, Inc., maintains a separate primary IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, demonstrating the company's significant role as a critical pharmaceutical vendor supporting military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F8XLQ?
SPE2DR26F8XLQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F8XLQ worth?
The government has obligated $22,856 on SPE2DR26F8XLQ.
Is contract SPE2DR26F8XLQ an order under another contract?
Yes. SPE2DR26F8XLQ is a delivery order under SPE2DR25D1208, an indefinite delivery contract.
Was contract SPE2DR26F8XLQ competed?
The extent of competition for SPE2DR26F8XLQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award